Adhera Therapeutics (ATRX) Short Interest Ratio & Short Volume

Short interest is the volume of Adhera Therapeutics shares that have been sold short but have not yet been covered or closed out. As of March 15th, traders have sold 100 shares of ATRX short. Learn More on Adhera Therapeutics' current short interest.

Adhera Therapeutics saw a drop in short interest in March. As of March 15th, there was short interest totaling 100 shares, a drop of 95.0% from the previous total of 2,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Adhera Therapeutics: SciSparc Ltd. (3.09%), RespireRx Pharmaceuticals Inc. (0.01%), eFFECTOR Therapeutics, Inc. (16.84%), Propanc Biopharma, Inc. (0.02%), Lucy Scientific Discovery Inc. (0.24%), Predictive Technology Group, Inc. (0.00%), IMV Inc. (1.31%), RegeneRx Biopharmaceuticals, Inc. (0.01%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Cummins Inc. ($8.93 billion), Canadian Natural Resources Limited ($7.79 billion), Super Micro Computer, Inc. ($4.31 billion), T-Mobile US, Inc. ($4.00 billion), General Motors ($3.36 billion), Occidental Petroleum Co. ($3.10 billion), Charter Communications, Inc. ($2.92 billion), Coinbase Global, Inc. ($2.74 billion), Tractor Supply ($2.72 billion), and Moderna, Inc. ($2.31 billion). View all of the most shorted stocks.

Short selling ATRX is an investing strategy that aims to generate trading profit from Adhera Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Adhera Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ATRX, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ATRX, twice per month. The most recent reporting period available is March, 15 2024.